Cannabis - Regulation - Delta-8- and Delta-10-Tetrahydrocannabinol
The legislation brings significant changes to Maryland's cannabis laws by refining definitions and expanding the framework for regulations. It prohibits the distribution of delta-8 and delta-10 products to minors and requires age verification measures for online sales. This establishes a more stringent regulatory environment aimed at protecting public health and safety, particularly among younger populations. Additionally, the Natalie M. LaPrade Medical Cannabis Commission is tasked with studying and recommending future regulations concerning tetrahydrocannabinols beyond delta-9.
Senate Bill 788 addresses the regulation of cannabis, specifically focusing on delta-8- and delta-10-tetrahydrocannabinol. The bill introduces a prohibition on the production of cannabis plants exceeding certain tetrahydrocannabinol concentrations and redefines terms related to marijuana and hemp products in the Maryland Controlled Dangerous Substances Act. It aims to outline clearer parameters for production and distribution, particularly for products sold to individuals under the age of 21, with strict penalties for violations.
The overall sentiment surrounding SB 788 is largely positive, particularly among proponents who view it as a necessary step toward clearer regulations in the burgeoning cannabis market. Supporters argue that the bill enhances consumer safety and addresses health concerns regarding specific tetrahydrocannabinol products. However, some dissenting voices express worries about potential over-regulation that could stifle market growth and innovation.
Notable points of contention include the definitions that may broaden what is considered marijuana to include various hemp-derived products, which could impose additional burdens on producers. Critics argue that the regulations might inadvertently limit beneficial uses of hemp-based products and create confusion in compliance for businesses. The bill aims to consult various stakeholders, indicating an attempt to balance regulation with industry needs, but concerns remain about the effectiveness of the defined regulations.